Cencora (COR)Chair sold ~$4.11M

~$4.11M

Approx. value · 15K sh @ $281.81

316K

Holds after · shares reported

Traded

Apr 22, 2025

Filed

Apr 23, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Feb 21, 2025InsiderOfficer sold ~$1.21M of COR shares in the open market
2. Feb 27, 2025Insider · 1 personInsiders: 2 sales (~$3.7M)
3. Mar 3, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
4. Mar 10, 2025InsiderOfficer sold ~$520K of COR shares in the open market
5. Mar 18, 2025Insider · 1 personInsiders: 2 sales (~$1.3M)
6. Mar 24, 2025FDARecall: Voriconazole Tablets, 50 mg, packaged in cartons of 3 blister cards with 10 individual blistered doses (30 Unit Dose per carton), Rx only, Distributed by: Amer…
7. Mar 24, 2025Insider · 1 personInsiders: 2 sales (~$1.1M)
8. Mar 25, 2025Insider · 1 personInsiders: 2 sales (~$3.9M)
9. Mar 27, 2025CongressDisclosed sale of COR — reported range $15,001 - $50,000
10. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100 mg/mL*, 1 x 1 mL Single-Dose Vial, Rx only, Manufactured by: Somerset Therapeutics Limited, #54/1, Boodhihal Village, Nela…
11. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 100mg/mL*, 5 x 1 mL Single-Dose Vials, Rx Only, Manufactured by: Somerset Therapeutics Limited, #54/1 Boodhihal Village, Nelam…
12. Apr 2, 2025FDARecall: Haloperidol Decanoate Injection, 50mg/mL* , 1 mL Single-Dose Vial, Rx only, Manufactured by Somerset Therapeutics Limited, 54/1, Boodhihal Village, Nelamangala…
13. Apr 21, 2025InsiderCEO sold ~$1.44M of COR shares in the open market
14. Apr 22, 2025 · this disclosureInsiderChair sold ~$4.11M of COR shares in the open market

What came next

1. May 12, 2025CongressDisclosed sale of COR — reported range $50,001 - $100,000
2. May 14, 2025InsiderDirector sold ~$837K of COR shares in the open market
3. May 15, 2025FDARecall: Indomethacin Extended-Release Capsules, USP, 75 mg, 30 capsules (3 x 10 blister cards) per carton, Rx Only, Distributed by: American Health Packaging, Columbus…
4. May 19, 2025InsiderCEO sold ~$1.45M of COR shares in the open market
5. May 20, 2025InsiderChair sold ~$4.28M of COR shares in the open market
6. May 29, 2025Insider · 1 personInsiders: 2 sales (~$867K)
7. Jun 18, 2025Insider · 2 peopleInsiders: 2 sales (~$2.7M)
8. Jun 24, 2025InsiderChair sold ~$4.27M of COR shares in the open market
9. Jul 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
10. Jul 22, 2025InsiderChair sold ~$4.27M of COR shares in the open market
11. Jul 29, 2025FDARecall: Sucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217 NDC 60687-695-01 - Carton NDC [6…
12. Aug 18, 2025InsiderCEO sold ~$1.46M of COR shares in the open market
13. Aug 19, 2025InsiderChair sold ~$4.23M of COR shares in the open market

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cencora

For Cencora, OQRO holds 7 insider filings (SEC Form 4 or Form 144), 1 Congress trade report, 29 fund holdings reports (13F) and 2 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COR page.

Other recent filings by Steven H Collis, Executive Chairman

• SEC Form 4 at Elevance Health (ELV)Mar 6, 2026
• SEC Form 4 at Cencora (COR)Sep 18, 2025
• SEC Form 4 at Cencora (COR)Aug 20, 2025
• SEC Form 4 at Cencora (COR)Jul 23, 2025
• SEC Form 4 at Cencora (COR)Jun 25, 2025

The full history of Steven H Collis, Executive Chairman is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Cencora

• SEC Form 4Oct 5, 2026
• SEC Form 4Sep 17, 2026
• SEC Form 144Sep 16, 2026
• SEC Form 144Sep 11, 2026
• SEC Form 144Sep 4, 2026
• SEC Form 4Sep 3, 2026

Everything OQRO holds on this company is on its COR page.